Cas 1010925-33-3,tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate

1010925-33-3

Post Buying Request

Basic information

Product Name: tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate
Synonyms: tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate
CAS NO:1010925-33-3
Molecular Formula: C19H23N3O5
Molecular Weight: 373.40302
EINECS: N/A
Product Categories: N/A
Mol File: 1010925-33-3.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate(1010925-33-3)
EPA Substance Registry System: tert-butyl 4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]piperazine-1-carboxylate(1010925-33-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1010925-33-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1010925-33-3 Suppliers

Recommended suppliersmore

1010925-33-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1010925-33-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,0,9,2 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1010925-33:
(9*1)+(8*0)+(7*1)+(6*0)+(5*9)+(4*2)+(3*5)+(2*3)+(1*3)=93
93 % 10 = 3
So 1010925-33-3 is a valid CAS Registry Number.

1010925-33-3Upstream product

1010925-33-3Downstream Products

1010925-33-3Relevant articles and documents

TARGETING HUMAN THYMIDYLATE KINASE INDUCES DNA REPAIR TOXICITY IN MALIGNANT TUMOR CELLS

-

, (2012/06/16)

The present invention relates to novel TMPK inhibitor compositions and their methods of use. In particular, it relates to novel TMPK inhibitor compositions and therapeutics that lead to dUTP-mediated DNA repair in tumor cells and acts as a novel chemosensitizer, which are useful in methods for treating or preventing cancers

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1010925-33-3